MedTrace Logo

Effect of Nursing Interventions on Pain and Salivary Cortisol Levels During Heel Stick in Preterm Newborns

NCT06628232 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2024-10-04

No results posted yet for this study

Summary

Babies born before the thirty-seventh gestational week are called preterm or premature. Most preterm newborns require Neonatal Intensive Care Unit (NICU) care depending on their gestational age and clinical condition. Although many painful invasive procedures are usually performed on newborns in the NICU, the most common procedure is heel prick. Heel prick is a painful and stressful procedure for the newborn. Neonates do not respond to pain verbally; they respond physiologically, behaviorally and hormonally. Physiologic responses of preterm infants to pain include increased heart and respiratory rate, increased blood pressure and intracranial pressure, decreased oxygenation, and sweating of palms. Among the hormonal symptoms caused by stress in newborns, the most commonly used biochemical method is the measurement of cortisol level. It is reported that there is a significant correlation between salivary and plasma cortisol levels and salivary cortisol level reflects plasma cortisol level. This method is particularly preferred because saliva sampling is much less stressful.

Conditions

  • PreTerm Neonate

Interventions

OTHER

pacifier with breast milk

swaddling in the mother\'s lap together with giving a pacifier dipped in breast milk

OTHER

heel heating

swaddling in the mother\'s lap together with local dry heat application

OTHER

interventions combined

swaddling in the mother\'s lap together with giving a pacifier dipped in breast milk and heel heating

OTHER

Control

swaddling the baby in the mother\'s lap

Sponsors & Collaborators

  • Namik Kemal University

    lead OTHER

Principal Investigators

  • Zeynem YILDIRIM BALKAN, Assist.Prof. · Namik Kemal University

  • Birsen Mutlu, Assoc.Prof. · Istanbul University - Cerrahpasa

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
34 Weeks
Max Age
36 Weeks
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-11-01
Primary Completion
2025-08-01
Completion
2025-11-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06628232 on ClinicalTrials.gov